uniQure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade uniQure 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About QURE

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. 

CEO
Matthew C. Kapusta
CEOMatthew C. Kapusta
Employees
209
Employees209
Headquarters
Amsterdam, Noord-Holland
HeadquartersAmsterdam, Noord-Holland
Founded
2012
Founded2012
Employees
209
Employees209

QURE Key Statistics

Market cap
1.56B
Market cap1.56B
Price-Earnings ratio
-5.77
Price-Earnings ratio-5.77
Dividend yield
Dividend yield
Average volume
1.57M
Average volume1.57M
High today
$28.77
High today$28.77
Low today
$23.50
Low today$23.50
Open price
$27.29
Open price$27.29
Volume
4.66M
Volume4.66M
52 Week high
$71.50
52 Week high$71.50
52 Week low
$7.76
52 Week low$7.76

Stock Snapshot

The current uniQure(QURE) stock price is $25.60, with a market capitalization of 1.56B. The stock trades at a price-to-earnings (P/E) ratio of -5.77.

As of 2026-01-11, uniQure(QURE) stock has fluctuated between $23.50 and $28.77. The current price stands at $25.60, placing the stock +8.9% above today's low and -11.0% off the high.

The uniQure(QURE)'s current trading volume is 4.66M, compared to an average daily volume of 1.57M.

In the last year, uniQure(QURE) shares hit a 52-week high of $71.50 and a 52-week low of $7.76.

In the last year, uniQure(QURE) shares hit a 52-week high of $71.50 and a 52-week low of $7.76.

QURE News

TipRanks 2d
uniQure announces Type A meeting scheduled with FDA

uniQure (QURE) announced a Type A meeting with the U.S. Food and Drug Administration has been scheduled to discuss the Biologics License Application data packag...

Analyst ratings

86%

of 14 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own QURE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.